Literature DB >> 5478286

p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine.

S J Strada, E Sanders-Bush, F Sulser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5478286     DOI： 10.1016/0006-2952(70)90012-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Rapid tolerance to the motor effects of p-chloroamphetamine in rats.

Authors:  M K El-Yousef; L Steranka; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1977-12-19       Impact factor: 4.530

2.  Evidence against serotonin involvement in the tonic component of electrically induced convulsions and in carbamazepine anticonvulsant activity.

Authors:  V Crunelli; S Bernasconi; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

3.  Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.

Authors:  A R Green; P H Kelly
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

4.  Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function.

Authors:  S O Ogren; C Johansson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Effect of phenmetrazine, aminorex and ( ) p-chloramphetamine on the motor activity and turnover rate of brain catecholamines.

Authors:  E Costa; K M Naimzada; A Revuelta
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

6.  Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.

Authors:  M G De Simoni; V Guardabasso; K Misterek; S Algeri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.